These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11904162)

  • 1. Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins.
    Masino L; Kelly G; Leonard K; Trottier Y; Pastore A
    FEBS Lett; 2002 Feb; 513(2-3):267-72. PubMed ID: 11904162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils.
    Bulone D; Masino L; Thomas DJ; San Biagio PL; Pastore A
    PLoS One; 2006 Dec; 1(1):e111. PubMed ID: 17205115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of expanded polyglutamine-domain proteins in Escherichia coli.
    Onodera O; Roses AD; Tsuji S; Vance JM; Strittmatter WJ; Burke JR
    FEBS Lett; 1996 Dec; 399(1-2):135-9. PubMed ID: 8980137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent toxicity gradient.
    Klein FA; Pastore A; Masino L; Zeder-Lutz G; Nierengarten H; Oulad-Abdelghani M; Altschuh D; Mandel JL; Trottier Y
    J Mol Biol; 2007 Aug; 371(1):235-44. PubMed ID: 17560603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglutamine Solution-State Structural Propensity Is Repeat Length Dependent.
    Jakubek RS; Workman RJ; White SE; Asher SA
    J Phys Chem B; 2019 May; 123(19):4193-4203. PubMed ID: 31008597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch.
    Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics analysis of the aggregation propensity of polyglutamine segments.
    Wen J; Scoles DR; Facelli JC
    PLoS One; 2017; 12(5):e0178333. PubMed ID: 28542401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular origin of polyglutamine aggregation in neurodegenerative diseases.
    Khare SD; Ding F; Gwanmesia KN; Dokholyan NV
    PLoS Comput Biol; 2005 Aug; 1(3):230-5. PubMed ID: 16158094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model.
    Li P; Huey-Tubman KE; Gao T; Li X; West AP; Bennett MJ; Bjorkman PJ
    Nat Struct Mol Biol; 2007 May; 14(5):381-7. PubMed ID: 17450152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA; Nagai Y; Onodera O; Inui T; Fujikake N; Urade Y; Strittmatter WJ; Burke JR; Ichikawa A; Toda T
    Biochem Biophys Res Commun; 2004 May; 317(4):1200-6. PubMed ID: 15094397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR spectroscopy as a tool for the rapid assessment of the conformation of GST-fusion proteins.
    Liew CK; Gamsjaeger R; Mansfield RE; Mackay JP
    Protein Sci; 2008 Sep; 17(9):1630-5. PubMed ID: 18556474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
    Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UV Resonance Raman Structural Characterization of an (In)soluble Polyglutamine Peptide.
    Jakubek RS; White SE; Asher SA
    J Phys Chem B; 2019 Feb; 123(8):1749-1763. PubMed ID: 30717595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A toxic monomeric conformer of the polyglutamine protein.
    Nagai Y; Inui T; Popiel HA; Fujikake N; Hasegawa K; Urade Y; Goto Y; Naiki H; Toda T
    Nat Struct Mol Biol; 2007 Apr; 14(4):332-40. PubMed ID: 17369839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.
    Takahashi T; Kikuchi S; Katada S; Nagai Y; Nishizawa M; Onodera O
    Hum Mol Genet; 2008 Feb; 17(3):345-56. PubMed ID: 17947294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Production of Monomeric Isotope-Enriched Aggregation-Prone Peptides: Polyglutamine Tracts and Beyond.
    Escobedo A; Chiesa G; Salvatella X
    Methods Mol Biol; 2020; 2141():211-231. PubMed ID: 32696359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.
    Wanker EE; Scherzinger E; Heiser V; Sittler A; Eickhoff H; Lehrach H
    Methods Enzymol; 1999; 309():375-86. PubMed ID: 10507036
    [No Abstract]   [Full Text] [Related]  

  • 19. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.
    Meriin AB; Zhang X; He X; Newnam GP; Chernoff YO; Sherman MY
    J Cell Biol; 2002 Jun; 157(6):997-1004. PubMed ID: 12058016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.
    Adegbuyiro A; Sedighi F; Pilkington AW; Groover S; Legleiter J
    Biochemistry; 2017 Mar; 56(9):1199-1217. PubMed ID: 28170216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.